Literature DB >> 11746185

Renal extracellular matrix alterations in lead-treated rats.

S Sánchez1, R Pérez Aguilar, S Genta, M Aybar, E Villecco, A Sánchez Riera.   

Abstract

Although the nephrotoxic effects of lead are well documented, the subcellular mechanisms of its action on the kidney remain unclear. The aim of the present work was to investigate the effects of chronic lead exposure on the expression of laminin-1 and fibronectin in the kidney of lead-treated rats. Western immunoblotting of the kidney extracts revealed that experimental exposure to lead resulted in a marked decrease in the intensity of the bands corresponding to laminin-1 and an increase in the intensity of the band corresponding to fibronectin. Immunohistochemical studies demonstrated a weak labelling to laminin-1 and a strong labelling to fibronectin in all renal basement membranes together with a decrease in their thickness. Other ultrastructural alterations found were a diminution in the amount of endothelial fenestrae, an increased fusion of foot processes in epithelial cells of the glomerulus and the presence of intranuclear inclusion bodies in the proximal tubule cells. Lead intoxication might be responsible for the above alterations in the renal extracellular matrix that could play an important role in the pathogenesis of lead nephropathy. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11746185     DOI: 10.1002/jat.775

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  2 in total

1.  A Visual and Ratiometric Chemosensor Using Thiophene Functionalized Hydrazone for the Selective Sensing of Pb2+ and F- Ions.

Authors:  Willsingh Anbu Durai; Andy Ramu; Amarajothi Dhakshinamoorthy
Journal:  J Fluoresc       Date:  2021-01-08       Impact factor: 2.217

2.  Long-Term Exposure of Lead Acetate on Rabbit Renal Tissue.

Authors:  Mohammad Hassan Karimfar; Afshar Bargahi; Darab Moshtaghi; Parviz Farzadinia
Journal:  Iran Red Crescent Med J       Date:  2016-02-06       Impact factor: 0.611

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.